These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1110 related articles for article (PubMed ID: 19759533)

  • 1. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.
    Thomas DL; Thio CL; Martin MP; Qi Y; Ge D; O'Huigin C; Kidd J; Kidd K; Khakoo SI; Alexander G; Goedert JJ; Kirk GD; Donfield SM; Rosen HR; Tobler LH; Busch MP; McHutchison JG; Goldstein DB; Carrington M
    Nature; 2009 Oct; 461(7265):798-801. PubMed ID: 19759533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C.
    Bellanti F; Vendemiale G; Altomare E; Serviddio G
    Clin Dev Immunol; 2012; 2012():849373. PubMed ID: 22966241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.
    Shi X; Pan Y; Wang M; Wang D; Li W; Jiang T; Zhang P; Chi X; Jiang Y; Gao Y; Zhong J; Sun B; Xu D; Jiang J; Niu J
    PLoS One; 2012; 7(5):e37054. PubMed ID: 22649509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.
    Kurbanov F; Abdel-Hamid M; Latanich R; Astemborski J; Mohamed M; Mikhail NM; El-Daly M; El-Kafrawy S; Thomas DL; Thio CL
    J Infect Dis; 2011 Nov; 204(9):1391-4. PubMed ID: 21933876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.
    Knapp S; Warshow U; Ho KM; Hegazy D; Little AM; Fowell A; Alexander G; Thursz M; Cramp M; Khakoo SI
    Gastroenterology; 2011 Jul; 141(1):320-5, 325.e1-2. PubMed ID: 21600205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors.
    Bes M; Sauleda S; Campos-Varela I; Rodriguez-Frias F; Casamitjana N; Homs M; Piron M; Quer J; Tabernero D; Guardia J; Puig L; Esteban JI
    J Viral Hepat; 2012 Dec; 19(12):867-71. PubMed ID: 23121365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response.
    Abdelwahab SF; Zakaria Z; Sobhy M; Hamdy S; Mahmoud MA; Mikhail N; Allam WR; Rewisha E; Waked I
    Arch Virol; 2015 Jul; 160(7):1741-50. PubMed ID: 25971683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.
    Taliani G; Spaziante M; Biliotti E; Borro M; Palazzo D; Grieco S; Franchi C; Iaiani G; Furlan C; Gallinaro V; Simmaco M
    PLoS One; 2013; 8(8):e67301. PubMed ID: 23936294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.
    Thong VD; Wasitthankasem R; Tangkijvanich P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2015; 10(5):e0125400. PubMed ID: 25938236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection.
    Keane C; O'Shea D; Reiberger T; Peck-Radosavljevic M; Farrell G; Bergin C; Gardiner CM
    PLoS One; 2013; 8(6):e66831. PubMed ID: 23826153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL28B and the control of hepatitis C virus infection.
    Balagopal A; Thomas DL; Thio CL
    Gastroenterology; 2010 Dec; 139(6):1865-76. PubMed ID: 20950615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients.
    Rosso C; Abate ML; Ciancio A; Strona S; Caviglia GP; Olivero A; Touscoz GA; Rizzetto M; Pellicano R; Smedile A
    World J Gastroenterol; 2014 Sep; 20(36):13146-52. PubMed ID: 25278709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection.
    Laird ME; Mohsen A; Duffy D; Mamdouh R; LeFouler L; Casrouge A; El-Daly M; Rafik M; Abdel-Hamid M; Soulier A; Pawlotsky JM; Hézode C; Rosa I; Renard P; Mohamed MK; Bonnard P; Izopet J; Mallet V; Pol S; Albert ML; Fontanet A
    J Hepatol; 2014 Oct; 61(4):770-6. PubMed ID: 24905490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population.
    Carapito R; Poustchi H; Kwemou M; Untrau M; Sharifi AH; Merat S; Haj-Sheykholeslami A; Jabbari H; Esmaili S; Michel S; Toussaint J; Le Gentil M; Ansari-Moghaddam A; Radosavljevic M; Etemadi A; Georgel P; Malekzadeh R; Bahram S
    Genes Immun; 2015 Dec; 16(8):514-8. PubMed ID: 26378651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
    Grebely J; Petoumenos K; Hellard M; Matthews GV; Suppiah V; Applegate T; Yeung B; Marks P; Rawlinson W; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ;
    Hepatology; 2010 Oct; 52(4):1216-24. PubMed ID: 20803561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.
    Duggal P; Thio CL; Wojcik GL; Goedert JJ; Mangia A; Latanich R; Kim AY; Lauer GM; Chung RT; Peters MG; Kirk GD; Mehta SH; Cox AL; Khakoo SI; Alric L; Cramp ME; Donfield SM; Edlin BR; Tobler LH; Busch MP; Alexander G; Rosen HR; Gao X; Abdel-Hamid M; Apps R; Carrington M; Thomas DL
    Ann Intern Med; 2013 Feb; 158(4):235-45. PubMed ID: 23420232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody-positive blood donors in China.
    Liu Y; Ma H; Chen S; Wang J; Liu G; Xu M; Ke L; He M
    Transfusion; 2013 Oct; 53(10 Pt 2):2498-504. PubMed ID: 23782163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians.
    Zheng MH; Li Y; Xiao DD; Shi KQ; Fan YC; Chen LL; Liu WY; Luo YW; Chen YP
    Gene; 2013 Apr; 518(2):479-82. PubMed ID: 23266640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.
    Abdelwahab SF; Zakaria Z; Allam WR; Hamdy S; Mahmoud MA; Sobhy M; Rewisha E; Waked I
    Arch Virol; 2015 Nov; 160(11):2833-7. PubMed ID: 26280523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.